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Down’s syndrome patients develop dementia similar
to Alzheimer’s disease and show elevated levels of
amyloid precursor protein in brain. Two papers in
this issue of Neuron show that reduced retrograde
transport or signaling of the neurotrophins NGF or
BDNF, respectively, may account for the neuronal
pathology in mouse models of Down’s syndrome.
Single hepatocytes can process metabolites, and indi-
vidual red blood cells can carry oxygen, but individual
neurons are useless when left alone. The brain is a net-
work of neurons, and individual neurons only work when
they are in touch with other neurons through synaptic
contacts. Connections between neurons are not ran-
dom but are constantly remodeled and tuned to opti-
mally reflect the external or internal environment of the
organism. The first hints about how this optimization
happens were revealed over half a century ago, when
Hamburger and Levi-Montalcini found that peripheral
sensory neurons were initially produced in excess dur-
ing development (Huang and Reichardt, 2001). When
their axons reached the target tissue, the majority of
neurons died, and only those that had established
a functional contact with the target remained. Levi-Mon-
talcini correctly predicted that the remaining neurons
survived because they had access to a diffusible factor
released from the target cells in limiting amounts. Sub-
sequent work led to the identification of this factor,
nerve growth factor (NGF), and the other members of
the neurotrophin family, brain-derived neurotrophic
factor (BDNF) and neurotrophins 3 and 4 (Huang and
Reichardt, 2001). It should be noted that the physiolog-
ical role of neurotrophins is not just to keep neurons
alive but also to select-out among the excessively pro-
duced competing neurons those that have made an op-
timal connection with the target tissue. In the brain, the
innervating axon can greatly increase the release of
neurotrophins from the target neurons by actively stim-
ulating them. This ensures that the established neuronal
connections and networks that they form are synapti-
cally active. Maintenance of connections within func-
tional neuronal networks in the adult brain requires
continuous access to the trophic factor that is released
by target neurons in an activity-dependently manner
(Huang and Reichardt, 2001). Thus, one critical task
for the individual neuron is to keep in touch with the
network.
Failures in the structure or function of neuronal net-
works critical for cognitive processes may lead to
dementia. Many patients with Down’s syndrome (DS, tri-
somy 21, Ts21) develop dementia, which shares fea-
tures with early-onset AD. At least partially, the in-
creased risk of dementia is accounted for by the
increased gene dosage of the amyloid precursor protein
(App) gene, which is located in the Ts21 region. In this is-sue of Neuron, two groups have investigated the role of
neurotrophins in the pathophysiology of DS by analyzing
mice with triplications in mouse chromosome 16 (Ts16),
which carries genes homologous to those in human chro-
mosome 21. These studies shed light not only on the role
of neurotrophins in DS, but on the general neurobiology of
dementia.
Neurotrophins act by binding to their receptors, either
Trk family receptor tyrosine kinases or the p75 neurotro-
phin receptor (Huang and Reichardt, 2001). BDNF re-
ceptor TrkB is alternatively spliced into a kinase-
containing isoform or a truncated, dominant-negative
isoform TrkB.T1. The expression of different TrkB splice
variants is associated with cognitive capacity: while
overexpression of the kinase-containing form enhances
memory and learning in transgenic mice (Koponen et al.,
2004), overexpression of the TrkB.T1 isoform in adult
neurons impairs long-term memory (Saarelainen et al.,
2000). Receptor-bound neurotrophins get internalized
into presynaptic terminals and are retrogradely trans-
ported to neuronal soma. Retrograde transport of tar-
get-derived growth factors is a critical process whereby
the metabolic machinery of the cell soma is kept in-
formed about the status of target innervation. The ces-
sation of flow of the target-derived factors indicates
that the neuron no longer has a functional contact with
the target.
Salehi, Mobley, and coworkers (Salehi et al., 2006)
have examined mouse models with a segmental trisomy
16 and analyze the retrograde transport of NGF within
the basal forebrain cholinergic neurons (BFCNs), which
are known to degenerate early in AD and which can be
rescued by NGF (Cooper et al., 2001). They demonstrate
that in Ts65Dn mice, retrograde transport of NGF is
greatly diminished and this effect correlates with the re-
duction in number and size of BFCNs. They then provide
several lines of evidence that suggest that the de-
creased retrograde transport of NGF is produced by
the increased expression levels of App. First, they
show that NGF transport is much less affected in an-
other DS model, where App levels are not increased,
and that these mice show no degeneration of the
BFCNs. Second, when they cross Ts65 mice with het-
erozygous App null mice, resulting in a mouse with nor-
mal App levels in the Ts65 background—NGF transport
is greatly improved and the degeneration of the BFCNs
is prevented. Third, they examined the retrograde trans-
port of NGF in the BFCNs in mice that overexpress either
the wild-type human App or App with mutations found in
early-onset AD patients and observed decreased NGF
transport in these mice. Interestingly, reduced NGF
transport was not correlated with an increase in Ab frag-
ment, but it did correlate with an increase in the C-termi-
nal fragments of App. The authors went on to provide
evidence that NGF and App are at least partially co-
localized in early endosomes, which are considered
the transport compartment, and that App-containing
early endosomes are abnormally large in the BFCNs of
the Ts65Dn mice. Importantly, the decreased retrograde
transport of NGF was not produced by a general
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fects in NGF binding or internalization, indicating that
the pathology may be confined to the transport of those
vesicles where NGF and APP are colocalized. Taken to-
gether, the results of Salehi et al. suggest a model in
which increased App levels in the early endosomes of
DS and AD model mice impairs the retrograde transport
of NGF and thereby brings about cholinergic neurode-
generation.
In the second paper, Dorsey, Tessarollo, and co-
workers examine another DS model, trisomy 16 (Ts16)
mice, which die before birth (Dorsey et al., 2006). The
authors build on their previous observation that cortical
neurons derived from Ts16 mice show reduced survival
in culture and cannot be rescued by the addition of
BDNF (Dorsey et al., 2002). Furthermore, Ts16 neurons
display increased levels of the dominant-negative
TrkB.T1 isoform of the BDNF receptor (Dorsey et al.,
2002). In the current paper, the authors test the hypoth-
esis that the increased expression of the TrkB.T1
causes the excess neuronal death in these mice. The
authors reduced the level of TrkB.T1 in Ts16 mice by in-
tercrossing the Ts16 mice and mice heterozygous for
a targeted deletion of the T1 isoform, thus generating
mice with normal TrkB.T1 levels on the Ts16 back-
ground. Remarkably, correction of the abnormal T1
levels rescues the cortical neurons, restores the resting
intracellular calcium levels in these neurons, and nor-
malizes their responsiveness to BDNF. Importantly, re-
duction of the TrkB.T1 to normal levels also reduces
the increased apoptosis in the cortex of Ts16 mouse
embryos in vivo to the level of euploid control mice.
These data are consistent with a model where in-
creased expression of TrkB.T1 in Ts16, through a dom-
inant-negative action or other mechanisms, prevents
neurons from taking advantage of the trophic support
provided by BDNF, which leads to degeneration and
death of cortical neurons. Although the authors do
not comment on other features of the Ts16/T1+/2
mouse phenotype, their data suggest that normaliza-
tion of the expression of a single gene can restore
a normal neuronal phenotype in the embryonic brain,
which is remarkable given that Ts16 produces a triplica-
tion of hundreds of genes.
Alzheimer’s disease (AD) is characterized by neuritic
plaques, neurofibrillary tangles, and loss of neurons, es-
pecially of BFCNs. However, early signs of AD include
loss of synapses and compromised axonal transport
(Stokin et al., 2005), while neuronal death occurs only
later. Interestingly, increased content of the TrkB.T1
and decreased catalytic TrkB has been observed in
AD patients (Ferrer et al., 1999), which suggest that,
similarly to the Ts16 mouse, neurons in AD cannot
take full advantage of BDNF. Furthermore, the bulk of
available evidence suggests that brain BDNF content
is diminished in cortex and hippocampus of AD pa-
tients. In contrast, cortical levels of NGF are normal or
elevated in most studies, while decreased levels have
been reported in BFCNs (Scott et al., 1995), which is
consistent with failed retrograde transport of NGF in
AD.
Although retrograde transport of NGF may fail in
both DS and AD, the underlying mechanisms are likely
to be different. Namely, App overproduction is notcommon in AD, but Ab accumulation results from ab-
normal processing of App or impaired Ab degradation.
Nevertheless, the results of Salehi and coworkers em-
phasize axonal transport as an Achilles’ heel of neu-
rons: inadequate retrograde transport blocks the ac-
cess of the cell soma to the trophic factor provided
by the target even if the target was functionally inner-
vated, which in turn may lead to degeneration. BFCNs
can be kept alive in Ts65Dn mice by injecting NGF
into the brain (Cooper et al., 2001), but this treatment
does not replace the critical role of the target-derived
factor, which is the maintenance of functional innerva-
tion. Indeed, providing neurons with the trophic factor
from a source other than the target may actually re-
duce the tendency of the remaining neurons to main-
tain or regain their target innervation. Thus, neuronal
death in AD may be a consequence of a disconnection
between neuronal soma and target rather than its
cause.
The common message of both of these papers is that
the inhibition of signaling or transport of a single neuro-
trophic factor may be partially responsible for the neu-
ronal pathology observed in DS mouse models, and
the same mechanisms may be affected also in AD. Sev-
eral questions remain open, however, and will no doubt
be subjects of further studies. Is the expression of
TrkB.T1 also increased in Ts65Dn mice, which survive
to adulthood? Would intercrossing of Ts65Dn mice
with the TrkB.T1 heterozygous mice influence the sur-
vival of BFCNs and the behavioral phenotype of these
mice? Since the TrkB gene is not located in mouse chro-
mosome 16, the mechanism that leads to increased
TrkB.T1 expression in the brain of Ts16 mice remains
unclear but may involve the regulation of alternative
splicing of the TrkB gene. Better understanding of the
splicing process might reveal mechanisms that could
become targets for novel drug therapy. Furthermore,
many issues in the role of App in NFG transport need
further clarification. Do the C-terminal fragments of
App resulting from a versus b secretase cleavage
equally interfere with NGF transport? If not, it may be
possible to rescue the transport defect in DS by phar-
macologically influencing the cleavage. Do App and
NGF interact in the early endosomes, and what is the
mechanism? Is TrkB also retrogradely transported in
the same endosomes, and might TrkB.T1 contribute to
the phenotype of these mice? Finally, designing and an-
alyzing new animal models that address the role of
TrkB.T1 in AD may further facilitate our understanding
of the role of neurotrophin signaling in neurodegenera-
tive diseases.
These two papers, together with other recent obser-
vations (Capsoni et al., 2000), indicate a revived interest
in the role of neurotrophic factors in dementia. Although
the results of these studies are still far from suggesting
any new therapeutic strategies for DS, it might be possi-
ble that drugs influencing App processing could in the
future help to restore the retrograde transport of NGF
and thereby cognitive symptoms in DS. In any case,
the papers provide interesting insights into the patho-
physiology of DS and underline the notion that the pri-
mary aim of treatment of neurodegenerative disorders
is not only to keep neurons alive but also to keep them
connected.
dancy in function, the intriguing spatial distribution of
these transporters may indicate unique roles for each
transporter. Several groups have demonstrated that
VGLUT1 and -2 show nonoverlapping, complementary
expression in the adult mouse brain (reviewed in
Takamori, 2006). Previous work by the research groups
of Robert Edwards and Roger Nicoll shed light on the
unique roles of VGLUTs by demonstrating that during
development different isoforms of VGLUTs may be
expressed within an individual cell, sorted into separate
vesicle populations, and released under different phases
of exocytosis (Fremeau et al., 2004).
Voglmaier et al. (2006) (this issue of Neuron) continue
to explore the functional differences between different
VGLUT isoforms. The authors, along with two other
groups (De Gois et al., 2006; Vinatier et al., 2006), identi-
fied an interaction between endophilin and a polyproline
(PP)-rich sequence at the C terminus of VGLUT1. Endo-
philin is known to be involved in synaptic vesicle recy-
cling from the plasma membrane (Guichet et al., 2002).
To examine the influence that endophilin has on VGLUT1
endocytosis, Voglmaier et al. fused the pH-sensitive
form of GFP, pHluorin, to the lumenal region of VGLUT1
and expressed it in hippocampal cultures. Since the
lumen of the synaptic vesicle is acidic and pHluorin is
essentially nonfluorescent at low pH, the pHluorin-
tagged constructs brighten upon exocytosis and dim
after endocytosis when the vesicle reacidifies (Miesen-
bock et al., 1998). VGLUT-pHluorin and DPP VGLUT1-
pHluorin (without the PP sequence that binds endophi-
lin) show similar levels of exo- and endocytosis at low
frequency and relatively short duration stimulations.
However, when stimulated at higher frequencies and
for longer durations, more of the DPP VGLUT1 mutant
becomes stranded on the cell surface than wild-type
VGLUT1. At the cessation of stimulation, endocytosis
of both constructs proceeds rapidly at similar rates.
Using pharmacological tools to rule out effects on
exocytosis and/or vesicle acidification, the authors
demonstrated that the differences in fluorescent signal
observed with the various VGLUT1 constructs were
due to alterations in endocytosis. Moreover, by remov-
ing the domains of endophilin and VGLUT1 that inter-
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Cargo after Exocytosis
In this issue of Neuron, Voglmaier et al. provide new
evidence that the retrieval of synaptic vesicle trans-
porters after exocytosis proceeds along at least two
different endocytic pathways. This work provides
new insight into the mechanisms of sorting synaptic
vesicle cargo at the cell surface.
The most abundant excitatory neurotransmitter in the
central nervous system is glutamate, which is packaged
into synaptic vesicles via a family of vesicular glutamate
transporters (VGLUTs). Three highly homologous VGLUT
genes in the mammalian CNS have been identified, each
with very similar biochemical transport properties.
Although the similarity in these proteins suggests redun-
act with each other and replacing them with exogenous
interacting domains, the authors were able to reconsti-
tute wild-type rates of endocytosis during prolonged
stimulation. Taken together these results strongly sug-
gest that the interaction between endophilin and
VGLUT1 is important for the retrieval of vesicular pro-
teins (at least a subset), but only during prolonged high-
frequency trains of action potentials, and that the endo-
philin-VGLUT1 interaction is not crucial for poststimulus
retrieval.
Although not a major point in the paper, the authors
also show that VGLUT1-pHluorin’s fluorescent signal
decayed faster than the widely used SV snare VAMP-
pHluorin. If the reported difference in decay rates follow-
ing exocytosis reflects endocytosis (rather than lateral
diffusion of the protein or some other factor), then this
result suggests distinct routes of internalization for the
different proteins. Since VAMP and VGLUT1 are eventu-
ally repackaged at the correct stoichiometry into new
SVs, but internalized via different routes, cargo mixing
and sorting must occur at later steps.
